All News #Library
Biotech
ARTBIO Initiates AB001 Dosing In ARTISAN, Phase 1 Trial
12 Jan 2026 //
PR NEWSWIRE
ARTbio Partners with 3B Pharma for Alpha Radioligand Therapy
14 Nov 2024 //
PR NEWSWIRE
ARTBIO Partners with 3B Pharma on Alpha Radioligand for Tumors
13 Nov 2024 //
PR NEWSWIRE
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
14 May 2024 //
BUSINESSWIRE

Market Place
Sourcing Support